Back

Multidimensional assessment of myocardial fibrosis in coronary heart disease using 18F-FAPI-04 PET/MRI

28 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Determinants of outcomes in acute myocardial infarction: risk factors, coronary and myocardial pathophysiology, and healthcare disparities ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Bo Zhang

First Affiliated Hospital of Dalian Medical University, Dalian (China)

4 More presentations in this session

Presentation thumbnail
Hospital-level disparities and long-term survival in patients with ST-segment elevation myocardial infarction: evidence from a nationwide cohort study
Professor F. Chen (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Predictors of functional decline after 6 months in elderly patients with NSTEMI
Mr C. Stadelmaier (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
The SMuRFs paradox in STEMI: insights from a metropolitan STEMI network
Doctor N. Gehrmann (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Prevalence and outcome of occluded coronary arteries in non-ST-segment elevation myocardial infarction patients in a high-volume primary percutaneous coronary intervention centre
Doctor O. Elsiraffy (Ashford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Determinants of outcomes in acute myocardial infarction: risk factors, coronary and myocardial pathophysiology, and healthcare disparities

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Fibroblast activation following myocardial infarction and left ventricular remodelling
19 May 2024
thumbnail
Congress Presentation
Clinical application of the fourth universal definition of myocardial infarction
2 September 2019
thumbnail
Congress Presentation
Safety, tolerability and diagnostic ability of a novel 18F-labelled tracer, [18F]SYN2, for PET myocardial perfusion imaging (SAFER) in patients with suspected coronary artery disease - phase II trial
20 May 2024
thumbnail
Congress Presentation
Clinical and prognostic significance of abnormal 18F-FDG PET findings in patients with cardiomyopathy
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources